Blackbrook Management Group

Valencia Technologies, incorporated in 2011 and based in Valencia, California, specializes in developing and manufacturing neuro modulation technologies aimed at treating major chronic conditions. The company's flagship product is the eCoin Peripheral Neurostimulator, a small, fully-implanted device designed to stimulate peripheral nerves. This platform electroceutical can be placed subcutaneously through an outpatient procedure and is used to treat various chronic conditions, including overactive bladder, hypertension, heart failure, depression, obesity, erectile dysfunction, and others. Notably, the eCoin system is FDA-approved for treating Urge Urinary Incontinence (UUI) and delivers automatic tibial nerve stimulation without the need for external remotes, lead wires, or recharge requirements. The procedure for implanting the device is minimally invasive, requiring only local anesthesia.

Pathology Watch Inc. is a company that specializes in providing remote specimen interpretation services through its digital pathology solution, primarily for hospitals, laboratories, and dermatology centers. Founded in 2017 and headquartered in Salt Lake City, Utah, the company collaborates with dermatopathologists and subspecialized pathologists to interpret digital slides, pathology reports, and biopsy slides. By digitizing the pathology workflow, Pathology Watch enhances the quality of patient care while reducing costs and creating new revenue opportunities for clinical practices. Additionally, the company offers telepathology services tailored for large clinics and hospitals, ensuring efficient and effective pathology services.